| abstract |
Compounds for the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compound has the following formula (Ia), including stereoisomers and pharmaceutically acceptable salts thereof, wherein A ', R1, R2 and R3 are as defined herein. Also disclosed are treatments and methods of use related to the compound, a pharmaceutical composition comprising the compound, and an intermediate compound and a method for preparing the same. |